Cargando…

An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression

BACKGROUND: Trastuzumab is a targeted therapy for human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, trastuzumab-induced cardiotoxicity (TIC) has been reported when trastuzumab is administered to patients as a single agent or combined with anthracycline. Currently no me...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ling, Allen, Read, Jia, Lin, Sun, Ting, Isakoff, Steven J., Scherrer-Crosbie, Marielle, Kehlmann, Allison M., Zheng, Hui, Ly, Amy, Walmsley, Charlotte S., Hesler, Katherine, Varasteh, Ava N., Pinto, Christopher J., McLoughlin, Daniel E., Wu, Wenjin, Wang, Xinhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113547/
https://www.ncbi.nlm.nih.gov/pubmed/35592673
http://dx.doi.org/10.3389/fonc.2022.809715